AU697785B2 - Analytical element,composition and method using modified apo-horseradish peroxidase - Google Patents

Analytical element,composition and method using modified apo-horseradish peroxidase Download PDF

Info

Publication number
AU697785B2
AU697785B2 AU24926/95A AU2492695A AU697785B2 AU 697785 B2 AU697785 B2 AU 697785B2 AU 24926/95 A AU24926/95 A AU 24926/95A AU 2492695 A AU2492695 A AU 2492695A AU 697785 B2 AU697785 B2 AU 697785B2
Authority
AU
Australia
Prior art keywords
peroxidase
labeled
apo
specific binding
immunoreactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU24926/95A
Other languages
English (en)
Other versions
AU2492695A (en
Inventor
Roy Eugene Snoke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Johnson and Johnson Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Clinical Diagnostics Inc filed Critical Johnson and Johnson Clinical Diagnostics Inc
Publication of AU2492695A publication Critical patent/AU2492695A/en
Application granted granted Critical
Publication of AU697785B2 publication Critical patent/AU697785B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU24926/95A 1994-07-19 1995-07-11 Analytical element,composition and method using modified apo-horseradish peroxidase Expired AU697785B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27739194A 1994-07-19 1994-07-19
US08/277391 1994-07-19

Publications (2)

Publication Number Publication Date
AU2492695A AU2492695A (en) 1996-02-01
AU697785B2 true AU697785B2 (en) 1998-10-15

Family

ID=23060663

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24926/95A Expired AU697785B2 (en) 1994-07-19 1995-07-11 Analytical element,composition and method using modified apo-horseradish peroxidase

Country Status (7)

Country Link
US (1) US5776714A (fr)
EP (1) EP0693552B1 (fr)
JP (1) JP3715348B2 (fr)
AT (1) ATE236246T1 (fr)
AU (1) AU697785B2 (fr)
CA (1) CA2154013C (fr)
DE (1) DE69530148T2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19628484A1 (de) * 1996-07-15 1998-01-22 Boehringer Mannheim Gmbh Blutersatzmittel-Entstörung durch Peroxide
CA2270797A1 (fr) * 1998-07-27 2000-01-27 Bayer Corporation Membrane d'ecoulement transparente pour dispositifs reactifs analytiques secs
EP1307741A4 (fr) * 2000-07-26 2005-11-23 Biodiagnostics Inc Procede destine a diagnostiquer des maladies de la thyroide et a controler la therapie par thyroxine
US7348147B2 (en) * 2004-11-15 2008-03-25 Carestream Health, Inc. Method and system for nucleic acid detection
US7183119B2 (en) * 2004-11-15 2007-02-27 Eastman Kodak Company Method for sensitive detection of multiple biological analytes
US7074622B2 (en) * 2004-11-15 2006-07-11 Eastman Kodak Company Method and system for sorting and separating particles
EP2057461A2 (fr) * 2006-08-17 2009-05-13 Atonomics A/S Amplification de biorésonateur à ondes acoustiques de surface (saw) pour la détection d'une substance à analyser cible
US8008035B2 (en) 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
EP1949894B1 (fr) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Amélioration des inhibiteurs de phosphatase contenant du vanadium avec des polyols
CN111518780B (zh) * 2020-06-04 2022-06-14 郑州伊美诺生物技术有限公司 脱辅基辣根过氧化物酶的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007462A1 (fr) * 1985-06-06 1986-12-18 Amersham International Plc Analyse enzymatique de fluides somatiques
EP0587222A2 (fr) * 1992-08-31 1994-03-16 Johnson & Johnson Clinical Diagnostics, Inc. Eléments secs avec une couche absorbante séparée pour immunoessais

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992158A (en) 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
US3905872A (en) 1973-12-14 1975-09-16 American Cyanamid Co Alkaline phosphatase test material
US4089747A (en) 1976-08-09 1978-05-16 Eastman Kodak Company Compositions for the detection of hydrogen peroxide
US4376165A (en) * 1978-06-22 1983-03-08 Miles Laboratories, Inc. Method of preparing an enzyme-labeled ligand for use in specific binding assays and the labeled conjugate produced thereby
US4258001A (en) 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
JPS55164356A (en) 1979-06-08 1980-12-22 Fuji Photo Film Co Ltd Multi-layer analysis sheet for liquid sample analysis
JPS6021370B2 (ja) 1979-11-05 1985-05-27 富士写真フイルム株式会社 写真感光材料
JPS5767860A (en) 1980-10-15 1982-04-24 Fuji Photo Film Co Ltd Material for multilayer analysis
JPS57101761A (en) 1980-12-17 1982-06-24 Konishiroku Photo Ind Co Ltd Analyzing element
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
JPS57200862A (en) 1981-06-05 1982-12-09 Fuji Photo Film Co Ltd Mutilayer analysis element utilizing unique binding reaction
JPS5845557A (ja) 1981-09-14 1983-03-16 Yatoron:Kk 過酸化水素定量用試薬
DE3225331A1 (de) 1982-07-07 1984-01-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung von direktem und gesamt-bilirubin sowie hierfuer geeignetes reagens
JPS5925699A (ja) 1982-08-03 1984-02-09 Torii Yakuhin Kk 酵素活性測定方法
EP0116454B1 (fr) 1983-02-11 1987-04-29 National Research Development Corporation Essai luminescent ou luminométrique amélioré
JPS59193352A (ja) 1983-04-18 1984-11-01 Fuji Photo Film Co Ltd 分析試薬および多層化学分析要素
US4670385A (en) 1984-05-21 1987-06-02 Eastman Kodak Company Compositions and elements containing triarylmethane leuco dyes and methods using same
GB8420053D0 (en) 1984-08-07 1984-09-12 Secr Social Service Brit Enhanced luminescent/luminometric assay
US4670381A (en) 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US4828983A (en) 1986-07-10 1989-05-09 Eastman Kodak Company Use of phenols and anilines to increase the rate of peroxidase catalyzed oxidation of leuco dyes
US4828978A (en) 1987-09-18 1989-05-09 Eastman Kodak Company Agglutination reagent and method of preparing same
US4997772A (en) 1987-09-18 1991-03-05 Eastman Kodak Company Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
US5177023A (en) 1987-08-03 1993-01-05 Eastman Kodak Company Water-insoluble reagent elements containing same and methods of use
US4892817A (en) 1987-09-21 1990-01-09 Biogenex Laboratories Stable phosphatase substrate composition
ATE137805T1 (de) 1989-02-14 1996-05-15 Wako Pure Chem Ind Ltd Verfahren zur erhöhung von chemilumineszenz
US5162219A (en) 1990-06-18 1992-11-10 Eastman Kodak Company Preparation of amine-enriched proteins having an increased isoelectric point
US5147777A (en) 1990-06-18 1992-09-15 Eastman Kodak Company Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use
EP0517327B1 (fr) 1991-06-07 2001-08-16 Johnson & Johnson Clinical Diagnostics, Inc. Essai immunologique utilisant des analogues d'haptènes marqués
CA2062176A1 (fr) 1991-06-07 1992-12-08 Glen M. Dappen Methode d'enduction de pellicules minces faisant appel au procede de couchage par gravure
US5372932A (en) 1992-12-22 1994-12-13 Eastman Kodak Company Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007462A1 (fr) * 1985-06-06 1986-12-18 Amersham International Plc Analyse enzymatique de fluides somatiques
EP0587222A2 (fr) * 1992-08-31 1994-03-16 Johnson & Johnson Clinical Diagnostics, Inc. Eléments secs avec une couche absorbante séparée pour immunoessais

Also Published As

Publication number Publication date
JP3715348B2 (ja) 2005-11-09
JPH08170961A (ja) 1996-07-02
DE69530148T2 (de) 2004-01-08
DE69530148D1 (de) 2003-05-08
AU2492695A (en) 1996-02-01
EP0693552A2 (fr) 1996-01-24
ATE236246T1 (de) 2003-04-15
EP0693552B1 (fr) 2003-04-02
CA2154013A1 (fr) 1996-01-20
CA2154013C (fr) 2006-12-19
EP0693552A3 (fr) 1996-04-03
US5776714A (en) 1998-07-07

Similar Documents

Publication Publication Date Title
US5714340A (en) Immunoassay elements having a receptor zone
US5155024A (en) Binder composition and analytical element having stabilized peroxidase in layer containing the composition
US5372932A (en) Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer
US5776714A (en) Analytical, element, composition and method using modified apo-horseradish peroxidase
US4874692A (en) Binder composition and analytical element having stabilized peroxidase in layer containing the composition
US5366864A (en) Buffered wash composition, insolubilizing composition, test kits and method of use
EP0848819B1 (fr) Element et procede analytique de determination d'un ligand specifique de liaison utilisant la bromoperoxydase de vanadium comme enzyme generatrice de signaux
US5696193A (en) Immunoassay elements comprising polymers containing vandium IV (V+4) ions
EP0687910B1 (fr) Garniture d'analyse et méthode pour un essai de liaison spécifique compétitive
EP0253581A1 (fr) Dispositif d'analyse ayant des polymères hydrosolubles et détermination utilisant ce dispositif
EP0603962B1 (fr) Eléments d'essais immunologiques à couche de récepteurs séparées
US5565326A (en) Separation-free specific binding assays using anti-inhibitor antibodies
EP0517338B1 (fr) Elément d'analyse revêtu par un procédé de gravure
Rubtsova et al. Chemiluminescent immunoassay: Application of a portable scanning luminometer for the determination of 2, 4‐dichlorophenoxyacetic acid in microtiter and membrane strip format
JP3727661B6 (ja) シグナル発生酵素としてバナジウムブロモペルオキシダーゼを使った特異的結合リガンドの測定用の分析要素および方法
WO1990005914A1 (fr) Systeme d'analyse de diagnostic biologique
JPH01316660A (ja) 物質の免疫学的検出方法及びこれに使用する組成物及びテストキット